Coordination and Locomotor Problems in Patients With Covid-19 Virus
Primary Purpose
Covid19, Motility Disorder, Balance
Status
Unknown status
Phase
Not Applicable
Locations
Hungary
Study Type
Interventional
Intervention
Neurology test
Sponsored by
About this trial
This is an interventional treatment trial for Covid19 focused on measuring 6MWT, Berg balance, Beam Walking
Eligibility Criteria
Inclusion Criteria:
- COVID 19 diagnosis
Exclusion Criteria:
- Severe heart problems
- severe demeanor
- alcoholism
- drug problems
Sites / Locations
- Dr. József Tollár
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
COVID19
Controll
Arm Description
Outcomes
Primary Outcome Measures
EQ5D-5L
Questionnaire
Berg test
Fatigue questionnaire
SPPB test (gait, balance, leg stregth)
Walking and balance testing
6MWT
Walking test
Secondary Outcome Measures
Full Information
NCT ID
NCT04734717
First Posted
February 1, 2021
Last Updated
February 1, 2021
Sponsor
Somogy Megyei Kaposi Mór Teaching Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04734717
Brief Title
Coordination and Locomotor Problems in Patients With Covid-19 Virus
Official Title
Coordination and Locomotor Problems in Patients With Covid-19 Virus
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 12, 2021 (Actual)
Primary Completion Date
April 12, 2021 (Anticipated)
Study Completion Date
April 12, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Somogy Megyei Kaposi Mór Teaching Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Coordination and Locomotor Problems in Patients With Covid-19 Virus
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Covid19, Motility Disorder, Balance
Keywords
6MWT, Berg balance, Beam Walking
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
COVID19
Arm Type
Experimental
Arm Title
Controll
Arm Type
Experimental
Intervention Type
Diagnostic Test
Intervention Name(s)
Neurology test
Intervention Description
movement examination of patients with covid19 disease
Primary Outcome Measure Information:
Title
EQ5D-5L
Description
Questionnaire
Time Frame
5 weeks-long
Title
Berg test
Description
Fatigue questionnaire
Time Frame
5 weeks-long
Title
SPPB test (gait, balance, leg stregth)
Description
Walking and balance testing
Time Frame
5 weeks-long
Title
6MWT
Description
Walking test
Time Frame
5 weeks-long
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
COVID 19 diagnosis
Exclusion Criteria:
Severe heart problems
severe demeanor
alcoholism
drug problems
Facility Information:
Facility Name
Dr. József Tollár
City
Kaposvár
State/Province
Somogy
ZIP/Postal Code
7400
Country
Hungary
12. IPD Sharing Statement
Plan to Share IPD
No
Links:
URL
https://pubmed.ncbi.nlm.nih.gov/?term=covid+19+cordination
Description
Related Info
Learn more about this trial
Coordination and Locomotor Problems in Patients With Covid-19 Virus
We'll reach out to this number within 24 hrs